Quality & Outcomes 1 subsource
CMS Care Compare HCAHPS — Hospital patient-experience survey The official hospital patient-experience survey: how patients rate communication, responsiveness, cleanliness, and their overall experience at each hospital, with star ratings and response rates by year.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Providers, Facilities & Health Systems 1 subsource
CMS Provider of Services (POS) File A profile of every Medicare-certified facility: what type it is, who controls it, where it sits, when it was certified, and its bed counts. The reference for facility characteristics across hospitals and other providers.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Drugs, Biologics & Devices 2 subsources
Drug Product Catalog (NDC) The FDA National Drug Code directory: 573,561 current NDCs (October 2026) with labeler, brand and generic name, strength, dosage form, route and marketing category, plus label-level safety details, and retained snapshots since 2016. The identity backbone that ties together the drug-pricing and formulary datasets.
Publisher
U.S. Food and Drug Administration
Source-backed product →
Providers, Facilities & Health Systems 2 subsources
Hospital Cost Reports (HCRIS) What it actually costs a hospital to deliver care, from the cost reports hospitals file with Medicare. Provides the cost-to-charge ratio for the whole hospital and for each department, turning a billed charge into an estimate of real cost, the basis reference-based-pricing vendors price against.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Hospital & Payer Price Transparency 10 subsources
Hospital Standard Charges (Price Transparency) Hospitals' posted prices from their federal price-transparency files (2026 files, collected August to October 2026): gross charges, cash prices, minimum and maximum negotiated rates, and the rate tied to each insurer and plan, procedure by procedure. Read one state at a time; many filed rows are placeholder (ghost) rates, so medians come from the comparable views.
Source-backed product with Vlada enrichment →
ACA Marketplace Plans 8 subsources
Individual Exchange ACA Individual Marketplace plans, plan years 2014 to 2026: plan definitions, benefits and cost sharing, filed premiums by plan, rating area and age, service areas, networks, rating rules, plan-year continuity, and issuer claims and appeals. Premiums are what members pay, not provider rates.
Publisher
Centers for Medicare & Medicaid Services / CCIIO
Source-backed product →
Medicare Advantage & Part D 4 subsources
Medicare Advantage & Part D Enrollment How many people are enrolled in each Medicare Advantage and Part D plan, tracked month by month down to the county level, back to 2006. The core measure of plan size, market share, and enrollment growth or decline.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 5 subsources
Medicare Advantage & Part D Plan Landscape The consumer-facing snapshot of every Medicare Advantage and Part D plan each year: premium, drug deductible, out-of-pocket maximum, star rating, and where the plan is offered. Includes Dual-Eligible Special Needs Plan (D-SNP) details such as plan type, integration status, and zero-dollar cost sharing.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product with Vlada enrichment →
Medicare Advantage & Part D 32 subsources
Medicare Advantage Plan Benefit Packages (PBP) The complete benefit design of every Medicare Advantage plan: the copays, coinsurance, deductibles, and coverage limits for every service, from inpatient hospital to ambulance, dental, vision, and hearing, plus optional supplemental benefits. Exactly what a plan covers and what a member pays out of pocket. Plan filings 2001 to 2027 (the 2027 filings are loaded); Plan Finder summaries 2020 to 2026.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 8 subsources
Medicare Fee-for-Service Utilization & Payments Provider-, service-, and geography-level Medicare utilization, submitted charges, allowed amounts, and payments across inpatient, outpatient, and professional care.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product with Vlada enrichment →
Medicare FFS Payments & Utilization 2 subsources
Medicare Hospital Outpatient (OPPS) Rates Medicare's payment rates for hospital outpatient services, the official benchmark for what a hospital outpatient procedure should cost. The correct yardstick for facility outpatient charges, distinct from physician fees.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Drugs, Biologics & Devices 4 subsources
Medicare Part B Drug Pricing & Utilization Medicare Part B drug payment benchmarks, NDC-to-HCPCS product mappings, annual spending, and administered-versus-discarded unit evidence.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 1 subsource
Medicare Part D Prescriber Utilization Prescriber-level Medicare Part D utilization and drug-spending evidence by provider and product.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 6 subsources
Medicare Physician Fee Schedule (PFS) CMS physician and professional-service payment rates with RVUs, conversion factors, GPCIs, carrier/locality geography, and historical ZIP-to-locality support.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Drugs, Biologics & Devices 1 subsource
NADAC — National Average Drug Acquisition Cost The national average price pharmacies pay to acquire a drug, surveyed weekly per NDC from late 2013 to September 2026. Distinct from list price or what a plan pays, and a baseline for judging drug markups. The generic methodology changed in December 2024; do not trend across it silently.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 10 subsources
Part D Plans & Formularies Medicare Part D plans and formularies from CMS's quarterly Part D files, 2019-Q1 to 2026-Q2: which plans cover a drug, at what tier and with what prior authorization, step therapy or quantity limits, member cost sharing, plan list unit costs and service areas, plus legacy Part D benefit detail from plan benefit filings. Prices are list unit costs, not net of rebates.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Providers, Facilities & Health Systems 4 subsources
Provider Enrollment & Ownership (PECOS) Who owns and is enrolled to bill Medicare: the enrollment records linking each provider to Medicare, the facilities clinicians are affiliated with, and the ownership records that reveal the parent companies and private-equity rollups behind hospitals, nursing homes, home health, and more.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product with Vlada enrichment →
The Spines 1 subsource
U.S. Geography Crosswalk (ZIP ↔ County ↔ CBSA ↔ State) The crosswalk from every U.S. ZIP code to its county, metro area (CBSA) and state, with population and location, from a single 2020 Census vintage. ZIP-to-county is a best-fit assignment, and the county FIPS code is not the CMS SSA county code.
Publisher
U.S. Census Bureau and federal health agencies
Coverage
2020 Census vintage
Vlada-integrated product →
The Spines 5 subsources
Vlada Provider & Facility Identity Vlada's resolved identity layer for clinicians, organizations, facilities, care sites, and health systems across NPI, CCN, TIN, location, affiliation, parent, and ownership identifiers.
Publisher
Vlada, assembled from public sources
Vlada-integrated product →
The Spines 6 subsources
Billing Code Intelligence The healthcare billing-code reference layer: code definitions and valid years, care-setting classification, revenue-code and hospital cost-center mappings, and the provider types that commonly perform each service.
Publisher
Vlada, assembled from public sources
Vlada-integrated product →
Quality & Outcomes 1 subsource
CMS Care Compare Home Health Agencies — per-agency quality Quality and profile data for each Medicare home health agency: patient-care star rating, key outcome measures, services offered, ownership, and Medicare spending. The home-health quality comparison layer.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Quality & Outcomes 1 subsource
CMS Care Compare Nursing Home (Provider Information) — 5-star quality The five-star quality profile of every Medicare and Medicaid nursing home: overall, health-inspection, quality-measure, and staffing ratings, plus beds, ownership, staffing hours, turnover, and enforcement history.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
CMS Medicare Geographic Variation County- and state-level variation in Medicare spending, utilization, quality, and beneficiary characteristics.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
CMS Medicare Market Saturation & Utilization CMS measures of Medicare fee-for-service provider concentration, service use and market saturation by county, for 24 service categories: a time series from the October 2014 to September 2015 window through calendar 2025 (quarterly rolling windows to 2023, then annual).
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Drugs, Biologics & Devices 1 subsource
CMS Open Payments (Sunshine Act) General payments that drug makers and group purchasing organizations report giving to physicians and teaching hospitals for drug and biological products, 2016 to 2025, linked to the provider and the drug. Device-only and non-product payments are not included. Used to surface financial ties that can sit behind prescribing.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
CMS Physician/Supplier Procedure Summary (PSPS) The most detailed public record of what Medicare allows for physician and supplier services: submitted, allowed, and denied service counts, charges, and payments for each billing code, broken out by provider specialty, locality, and place of service.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Quality & Outcomes 1 subsource
CMS Quality Payment Program Experience Clinician and practice participation, performance, and payment-adjustment experience under the Quality Payment Program.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Drugs, Biologics & Devices 3 subsources
FDA Orange Book The current FDA Orange Book (October 2026): approved drug products with their patents, exclusivity periods and therapeutic-equivalence ratings, used to work out when a brand drug's protections lapse. History is a set of irregular snapshots since March 2021 (with gaps, such as August 2023 to October 2024), not a continuous series. Patent and exclusivity dates are text in varying formats.
Publisher
U.S. Food and Drug Administration
Coverage
current; snapshots 2021-2026
Source-backed product →
Drugs, Biologics & Devices 1 subsource
FDA Purple Book — licensed biologics + biosimilars The current FDA Purple Book: 4,667 licensed biologic products, including 469 biosimilars, with reference products, interchangeability and exclusivity dates, plus sparse history snapshots since 2020. The reference for when biosimilar competition can begin.
Publisher
U.S. Food and Drug Administration
Coverage
current; snapshots 2020-2026
Source-backed product →
The Spines 1 subsource
ICD-10-CM Diagnosis Code Dimension The full set of ICD-10 diagnosis codes and their descriptions, by year. The diagnosis vocabulary used to read claim diagnoses, map them to risk categories, and interpret clinical conditions. All 16 fiscal-year code sets are held, FY2012 to FY2027. FY2021 to FY2025 are currently flagged non-current, so a query must request them explicitly (is_current = false) to read those five years.
Publisher
Centers for Disease Control and Prevention
Source-backed product →
Drugs, Biologics & Devices 1 subsource
IRA Maximum Fair Price (CMS-negotiated) The maximum fair prices CMS has negotiated for selected high-cost drugs under the Inflation Reduction Act, effective 2026 and 2027. The first federally negotiated Medicare drug prices.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Hospital & Payer Price Transparency 2 subsources
Massachusetts Commercial Hospital Price & Cost Benchmarks Massachusetts CHIA commercial hospital relative prices by payer and hospital, and revenue-to-cost ratios by payer class, data years 2018 to 2023. Relative price is an index (1.0 = the payer's network median), not dollars, and is not comparable across payers.
Publisher
Massachusetts Center for Health Information and Analysis
Source-backed product with Vlada enrichment →
Medicaid 1 subsource
Medicaid State Drug Utilization How much of each drug was dispensed and reimbursed under Medicaid, by state and quarter going back to 1991: units, prescriptions, and dollars, split between fee-for-service and managed care. The state-level view of Medicaid drug spending. Through 2026-Q1. Reimbursed amounts are gross of rebates.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 1 subsource
Medicare Advantage County Ratebook What CMS pays a Medicare Advantage plan per member in each county, by the county's quality-bonus tier. The revenue starting point behind every Medicare Advantage plan's economics.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 4 subsources
Medicare Advantage Plan Payments The money side of Medicare Advantage, 2006 to 2024: CMS's average payment per member per month, average risk scores and rebates by contract, plan and county, plus contracts' medical loss ratio filings. Payment values are averages (weight by member-months). Plan bid data is not included.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 9 subsources
Medicare Advantage Star Ratings CMS's one-to-five star ratings for Medicare Advantage and Part D contracts, rating years 2007 to 2026, with per-measure values and stars, cut points, the Categorical Adjustment Index and a cross-year measure crosswalk. For 2027 only CMS's preview cut points are held; 2027 contract ratings are not yet in the table.
Publisher
Centers for Medicare & Medicaid Services
Coverage
2007-2026; 2027 preview cut points
Source-backed product →
Medicare FFS Payments & Utilization 3 subsources
Medicare Ambulatory Surgery Center (ASC) Rates Medicare's payment schedule for surgeries done at ambulatory surgery centers, the correct benchmark for outpatient surgery in that setting, kept separate from hospital outpatient rates.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product with Vlada enrichment →
Medicare FFS Payments & Utilization 2 subsources
Medicare Clinical Laboratory Fee Schedule (CLFS) Medicare's national clinical lab fee schedule (national limitation amounts, 2019 to 2026) with the private-payer rates and volumes labs reported to CMS under PAMA (the 2018 and 2026 collections). Private-payer rows are individual reported observations, not benchmarks.
Publisher
Centers for Medicare & Medicaid Services
Coverage
2019-2026; PAMA 2018, 2026
Source-backed product →
Medicare FFS Payments & Utilization 4 subsources
Medicare Inpatient Prospective Payment System (IPPS) The components of a Medicare inpatient hospital payment: national base rates, hospital wage indexes and geography, and MS-DRG relative weights by fiscal year.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product with Vlada enrichment →
Medicare FFS Payments & Utilization 1 subsource
Medicare Post-Acute Care Utilization What Medicare paid post-acute providers, skilled nursing, home health, hospice, rehab, and long-term care hospitals, per provider: patients served, stays, days, charges, and payments.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Providers, Facilities & Health Systems 2 subsources
OIG Exclusions & Integrity Agreements The current HHS-OIG exclusion list (151,881 excluded individuals and entities as of September 2026) with monthly history snapshots since 2016, plus Corporate Integrity Agreements. NPI is often blank, so name matching is approximate.
Publisher
HHS Office of Inspector General
Coverage
current; history 2016-2026
Source-backed product →
Drugs, Biologics & Devices 1 subsource
VA Federal Supply Schedule (FSS) drug prices The prices the federal government negotiates for drugs through the VA supply schedule, by drug code. A government-negotiated benchmark that sits well below list price, useful as a low-water mark for drug pricing.
Publisher
U.S. Department of Veterans Affairs
Source-backed product →
Drugs, Biologics & Devices 1 subsource
Clinical Trials (ClinicalTrials.gov, drug-regulated) The registry of drug clinical trials: study title, status, phase, enrollment, sponsor, and whether results are posted. The development-pipeline and evidence context behind a drug.
Publisher
National Library of Medicine
Source-backed product →
Quality & Outcomes 1 subsource
CMS Care Compare Hospice provider-quality measures Quality scores for each Medicare hospice, measure by measure. The hospice piece of the picture when comparing post-acute care quality alongside hospitals, nursing homes, and home health.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Quality & Outcomes 2 subsources
CMS Dialysis Facilities & Quality Facility identity, ownership, services, stations, quality measures, and five-star ratings for Medicare-certified dialysis facilities.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product with Vlada enrichment →
Quality & Outcomes 1 subsource
CMS ESRD QIP Total Performance Score (dialysis pay-for-performance) How each dialysis facility scores on Medicare's dialysis quality program versus state and national averages, and the resulting payment penalty. The pay-for-performance layer for dialysis.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Quality & Outcomes 1 subsource
CMS Hospital Readmissions Reduction Program (HRRP) How each hospital performs on avoidable readmissions, by condition, with the excess-readmission ratios that determine whether a hospital faces a Medicare penalty.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Quality & Outcomes 1 subsource
CMS Hospital Value-Based Purchasing (HVBP) Total Performance Score How each hospital scores across Medicare's value-based purchasing domains, clinical outcomes, patient experience, safety, and cost, and the total score that adjusts its Medicare payments up or down.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
CMS Medicare Ambulance Fee Schedule (AFS) Public Use File Medicare's payment schedule for ambulance transport by service level and mileage, adjusted by locality. The benchmark for repricing ambulance claims, which sit outside the main fee schedules.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 2 subsources
CMS-HCC Risk Adjustment Model The diagnosis-to-HCC mappings and model coefficients used to translate member conditions into Medicare Advantage risk scores, rate years 2016 to 2027 across model versions (V21, V22, V24, V28, RxHCC). Pin the rate year and model version.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicaid 2 subsources
Connecticut Medicaid Inpatient Rates Connecticut Medicaid inpatient hospital base rates and DRG weights needed to construct facility- and case-specific payment benchmarks.
Publisher
Connecticut Department of Social Services
Source-backed product with Vlada enrichment →
Drugs, Biologics & Devices 1 subsource
Consumer cash-price reference (Cost Plus Drugs snapshot) A reference set of transparent consumer cash prices for drugs, currently from the Mark Cuban Cost Plus Drugs catalog, with the price, quantity, and a retail comparison. A low-cost consumer benchmark for a drug.
Publisher
Mark Cuban Cost Plus Drug Company
Source-backed product →
Drugs, Biologics & Devices 2 subsources
Drug Classification (RxClass) The system for grouping drugs into clinical and therapeutic classes by mechanism, chemical class, or treatment use, plus the map from each drug to its classes. Lets drugs be rolled up to a therapeutic category.
Publisher
National Library of Medicine
Source-backed product →
Drugs, Biologics & Devices 1 subsource
FDA Drug Applications (NDA/ANDA/BLA dimension) Every FDA drug application (NDA, ANDA, BLA) with its sponsor, submission history and status: 29,694 current applications, latest submission October 2026, with weekly snapshots since December 2019. The thread linking a drug to its approvals, labels and patents.
Publisher
U.S. Food and Drug Administration
Coverage
current; snapshots 2019-2026
Source-backed product →
Drugs, Biologics & Devices 1 subsource
FDA Drug Recalls (Enforcement Reports) The FDA's drug recall records: severity class, the product and reason, the recalling firm, and how far the product was distributed. A quality and safety signal for a drug book.
Publisher
U.S. Food and Drug Administration
Source-backed product →
Drugs, Biologics & Devices 1 subsource
FDA Drug Shortages The FDA's list of current and resolved drug shortages by product, with availability status, manufacturer, and cause. A supply-risk signal for a drug portfolio.
Publisher
U.S. Food and Drug Administration
Source-backed product →
Drugs, Biologics & Devices 1 subsource
FDA FAERS — Adverse-Event Drug Involvement (DRUG file) The drug side of the FDA's adverse-event reports, report quarters 2025-Q1 to 2026-Q2: for each reported event, which drugs were involved and whether each was the primary suspect, a secondary suspect or taken alongside. No earlier history; cases repeat across quarters, so counts overstate slightly.
Publisher
U.S. Food and Drug Administration
Coverage
2025-Q1 to 2026-Q2
Source-backed product →
The Spines 3 subsources
Form 5500 Filings & Service Providers Department of Labor Form 5500 filings with Schedule C service-provider relationships, compensation, and service-code detail for employer-sponsored benefit plans.
Publisher
U.S. Department of Labor
Source-backed product →
Providers, Facilities & Health Systems 2 subsources
HRSA 340B Covered Entities The federal registry of organizations eligible for 340B drug discounts, connected by Vlada to provider NPIs so covered entities can be analyzed with provider, facility, and drug data.
Publisher
Health Resources and Services Administration
Source-backed product →
Providers, Facilities & Health Systems 1 subsource
HRSA Health Professional Shortage Areas (HPSA) The federally designated areas short on primary care, dental, or mental health providers. Identifies underserved geographies and the providers eligible for shortage-area bonuses.
Publisher
Health Resources and Services Administration
Source-backed product →
The Spines 1 subsource
ICD-10-PCS Inpatient Procedure Code Dimension The full set of ICD-10 inpatient procedure codes and their descriptions, by year. The procedure vocabulary that feeds inpatient claim interpretation and diagnosis-group assignment. All 16 fiscal-year code sets are held, FY2012 to FY2027. FY2021 to FY2025 are currently flagged non-current, so a query must request them explicitly (is_current = false) to read those five years.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Hospital & Payer Price Transparency 2 subsources
Maryland All-Payer Hospital Rates & Volumes Maryland HSCRC all-payer hospital unit rates per hospital and cost center (rate years 2013 to 2024 and 2026; 2025 is not held) and monthly revenue and volumes per hospital and rate center (July 2016 to April 2026). Revenue is regulated charge revenue, not payments.
Publisher
Maryland Health Services Cost Review Commission
Source-backed product with Vlada enrichment →
Medicaid 1 subsource
Medicaid Drug Rebate Program — product file The reference list of drugs eligible for Medicaid rebates by drug code and quarter: manufacturer, product name, drug category, package size, and rebate status.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Providers, Facilities & Health Systems 1 subsource
Medicare ACO Participants The organizations taking part in each Medicare Shared Savings accountable care organization: which providers joined, their service area, agreement period, and track. Shows how providers are grouped into value-based arrangements.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 9 subsources
Medicare Advantage HEDIS Quality The HEDIS clinical quality measures behind Medicare Advantage star ratings, reported per contract: preventive screening, fall-risk management, readmissions, emergency use and other care-quality outcomes. Report years 2019 and 2021 to 2025 (CMS published no 2020 file); the report year is the publication year, measured one year earlier.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 2 subsources
Medicare DME Utilization & Rates What Medicare allows and pays for durable medical equipment, devices, and supplies, both per supplier and summarized by geography, code by code with volumes and average charges.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
Medicare FQHC Prospective Payment Rates CMS prospective payment rates for qualifying Federally Qualified Health Center services.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
Medicare Home Health PDGM Weights Home Health Patient-Driven Groupings Model case-mix weights used in Medicare home-health payment.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
Medicare Hospice Prospective Payment Rates CMS hospice payment rates by level of care and fiscal year.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
Medicare Inpatient Rehabilitation Facility PPS Weights IRF case-mix group weights used to calculate Medicare inpatient rehabilitation payments.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 1 subsource
Medicare Part D Spending by Drug (PUF) Annual Medicare Part D spending, claims, and beneficiary counts for each drug, with how unit costs move year over year. The big-picture view of which drugs drive Part D dollars.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
Medicare Skilled Nursing Facility PDPM Rates Skilled Nursing Facility Patient-Driven Payment Model component rates and case-mix weights.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Drugs, Biologics & Devices 1 subsource
NLM AccessGUDID — Device Identity (FDA Global UDI Database) The identity registry for every marketed medical device by its unique device identifier: brand, model, catalog number, maker, and safety attributes like single-use, sterile, and MRI compatibility.
Publisher
U.S. Food and Drug Administration · National Library of Medicine
Source-backed product →
The Spines 1 subsource
NUCC Healthcare Provider Taxonomy Code Set The standard code set that describes provider specialties, the vocabulary that decodes what kind of provider or specialty each identifier represents.
Publisher
National Uniform Claim Committee
Source-backed product →
Drugs, Biologics & Devices 1 subsource
WAC increases — California HCAI SB 17 notices Manufacturer notices of wholesale list-price increases on drugs, with their stated reasons, reported under California's price-transparency law. A public window into drug list-price hikes.
Publisher
California Department of Health Care Access and Information
Source-backed product →
Medicare FFS Payments & Utilization 1 subsource
CMS LTCH PPS MS-LTC-DRG Relative Weights (Table 11) The case-mix weights and length-of-stay figures Medicare uses to pay long-term care hospitals by diagnosis group. Used to reprice long-term care hospital stays.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Drugs, Biologics & Devices 1 subsource
FDA Drug Master Files (DMF) The public index of FDA Drug Master Files (number, type, status, holder and subject): 41,254 on the current list (July 2026), with history in irregular snapshots since 2020. The filings themselves are confidential; only the index is public. A supply-chain and ingredient-source reference.
Publisher
U.S. Food and Drug Administration
Coverage
current; snapshots 2020-2026
Source-backed product →
Drugs, Biologics & Devices 1 subsource
FDA Warning Letters The FDA's warning letters to companies: who was cited, for what, and when, with response and closeout dates. A regulatory-accountability signal on drug makers and firms.
Publisher
U.S. Food and Drug Administration
Source-backed product →
Providers, Facilities & Health Systems 1 subsource
Medicare Diabetes Prevention Program (MDPP) Suppliers The roster of organizations enrolled to deliver Medicare's diabetes prevention benefit, with name, location, and provider identifier. A participation list for this specific CMS program.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →
Medicare Advantage & Part D 1 subsource
Medicare Plan Crosswalks The year-to-year lineage of Medicare plans: which plans merged, were renamed, or terminated. The thread that lets enrollment be followed cleanly across plan-year boundaries.
Publisher
Centers for Medicare & Medicaid Services
Source-backed product →